Swati Speciality Private Limited
About Swati Speciality Private Limited
Data last updated:
Swati Speciality Private Limited is a private limited company based in Chhatral, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24304GJ2020PTC112808. Its GSTIN is 24AAICK0288R1ZX (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rai Adarsh Danesh (Whole-Time Director) and Ashutosh Radheshyam Tripathi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Survey No 1206/A Behind Shubh Laxmi Estate Chhatral Kadi Road Vill: Chhatral Tal:, Kalol, Gujarat, India – 382729.
As per the financials filed for FY 2025, the company reported a revenue of ₹2.92 Cr, a growth of 42% compared to the previous year. For the same year it recorded a net loss of ₹2.8 Cr (net margin -96.1%) and EBITDA of -₹78.95 Lakh (EBITDA margin -27.1%).
The company has about 30 employees on its provident fund (EPFO) records.
Company details
Contact details
Swati Speciality Private Limited's registered office is in Chhatral, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressSurvey No 1206/A Behind Shubh Laxmi Estate Chhatral Kadi Road Vill: Chhatral Tal:, Kalol, Gujarat, India – 382729
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Swati Speciality Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Swati Speciality is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Swati Speciality Private Limited, buy the company report.
Financials of Swati Speciality Private Limited
FY 2025 filings availableSwati Speciality Private Limited reported revenue of ₹2.92 Cr (up 42% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 42% in the latest year. EBITDA fell 40% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹78.95 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2.8 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -27.1% | ||||
| Net Profit Margin | -96.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Swati Speciality Private Limited, buy the company report.
Board of directors of Swati Speciality Private Limited
Swati Speciality has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashutosh Radheshyam Tripathi Also directs: Alcon Biosciences Private Limited | Director | 28 Jul 2023 | 3 Years 3 Months | Current |
| Rai Adarsh Danesh Also directs: Romano Drugs Private Limited | Whole-Time Director | 28 Jul 2023 | 3 Years 3 Months | Current |
Peer comparison
Swati Speciality Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Soft Rainbow Color Private Limited | ₹2.92 Cr (FY 2025) | 138.0% | Ahmedabad, Gujarat, India | |||
| Glexon Healthcare Private Limited | ₹2.92 Cr (FY 2025) | 90.0% | Ahmedabad, Gujarat, India | |||
| Saha Biological Pvt Ltd | ₹2.92 Cr (FY 2024) | 4.0% | Kolkata, West Bengal, India | |||
| Plight Pharma Private Limited | ₹2.92 Cr (FY 2025) | 20.0% | Nagpur, Maharashtra, India | |||
| Vclean Chemicals Private Limited | ₹2.92 Cr (FY 2025) | 27.0% | Kottayam, Kerala, India | |||
| Swati Speciality Private Limitedthis company | ₹2.92 Cr (FY 2025) | -₹2.8 Cr | -96.1% | 42.0% | 30 | Chhatral, Gujarat, India |
| Shree Vinayak India Bio-Fertilisers Private Limited | ₹2.91 Cr (FY 2024) | -56.0% | Dhar, Madhya Pradesh, India | |||
| Gumandev Chemicals Private Limited | ₹2.91 Cr (FY 2025) | -40.0% | Bharuch, Gujarat, India | |||
| Ramashary Pharma Machinery Private Limited | ₹2.91 Cr (FY 2024) | -10.0% | Mumbai, Maharashtra, India | |||
| Synryn Pharma Private Limited | ₹2.91 Cr (FY 2025) | -3.0% | Hyderabad, Telangana, India | |||
| Surya Microns Private Limited | ₹2.91 Cr (FY 2024) | 10.0% | Uttar Pradesh, India |
To see the full peer comparison of Swati Speciality Private Limited, buy the company report.
Auditor
Swati Speciality Private Limited is audited by BATHIYA & ASSOCIATES LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BATHIYA & ASSOCIATES LLP | FY 2023 | 101046W/W100063 |
Shareholding
The shareholding of Swati Speciality Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Swati Speciality Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Swati Speciality Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
Swati Speciality Private Limited has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 60 overdue payments to 28 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 28)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | |||
| BP Lubricants Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Swati Speciality Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Swati Speciality Private Limited has a workforce of 30 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 30 |
| FY 2025-26 | |
| FY 2024-25 |
To see the full employee and EPFO history of Swati Speciality Private Limited, buy the company report.
GST
Swati Speciality has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAICK0288R1ZX | Gujarat | Active | 25 Jul 2020 |
To see the full GST registrations and return filing status of Swati Speciality Private Limited, buy the company report.
Recent activity
Swati Speciality Private Limited has 6 board changes on record since 2020: 4 appointments and 2 cessations. The latest: Ashutosh Vishnubhai Patel ceased to be Director on 19 Aug 2023.
Frequently asked questions
Swati Speciality is an active private limited company based in Chhatral, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 February 2020 (6+ years old) and is registered under CIN U24304GJ2020PTC112808.
Swati Speciality has 2 current directors:
- Rai Adarsh Danesh - Whole-Time Director
- Ashutosh Radheshyam Tripathi - Director
The latest financial statements of Swati Speciality on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Swati Speciality is 24AAICK0288R1ZX, registered in Gujarat.
The CIN (Corporate Identification Number) of Swati Speciality is U24304GJ2020PTC112808. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Swati Speciality was incorporated on 19 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Swati Speciality by revenue are Soft Rainbow Color Private Limited, Glexon Healthcare Private Limited, Saha Biological Pvt Ltd, Plight Pharma Private Limited, Vclean Chemicals Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Ashutosh Vishnubhai Patel ceased to be Director on 19 Aug 2023. Kashyap Kirtikumar Patel ceased to be Director on 19 Aug 2023. Ashutosh Radheshyam Tripathi was appointed as Director on 28 Jul 2023. Swati Speciality has 6 board changes on record in total.
Swati Speciality has 4 MSME Form 1 returns on record for the period ending Sep 2023, listing 60 overdue payments to 28 micro and small suppliers. The latest return was filed on 17 Nov 2023.
The registered office of Swati Speciality is at Survey No 1206A Behind Shubh Laxmi Estate Chhatral Kadi Road Vill: Chhatral Tal:, Kalol, Gujarat, India – 382729.
Swati Speciality operates in the pharma industry, in the drug formulation and development segment.
Swati Speciality can be reached at its registered office: Survey No 1206A Behind Shubh Laxmi Estate Chhatral Kadi Road Vill: Chhatral Tal:, Kalol, Gujarat, India – 382729.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
